Cucurbitacin	B:C0056580
B	I:C0056580
Protects	O
Against	O
Pressure	O
Overload	O
Induced	O
Cardiac	O
Hypertrophy	I:C1383860
.	O

Cucurbitacin	O
B	I:C0056580
Protects	O
Against	O
Pressure	O
Overload	O
Induced	O
Cardiac	B:C1383860
Hypertrophy	I:C1383860
.	O

Lack	O
of	O
effective	O
anti-cardiac	B:C1254351
hypertrophy	I:C1254351
drugs	I:C1254351
creates	O
a	O
major	O
cause	O
for	O
the	O
increasing	O
prevalence	O
of	O
heart	O
failure	I:C0018801
.	O

Lack	O
of	O
effective	O
anti-cardiac	O
hypertrophy	I:C1254351
drugs	I:C1254351
creates	O
a	O
major	O
cause	O
for	O
the	O
increasing	O
prevalence	O
of	O
heart	B:C0018801
failure	I:C0018801
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
anti-hypertrophy	B:C0243095
and	O
anti-fibrosis	O
potential	O
of	O
a	O
natural	O
plant	I:C0032098
triterpenoid	O
,	O
Cucurbitacin	O
B	I:C0056580
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
anti-hypertrophy	O
and	O
anti-fibrosis	B:C0243095
potential	O
of	O
a	O
natural	O
plant	I:C0032098
triterpenoid	O
,	O
Cucurbitacin	O
B	I:C0056580
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
anti-hypertrophy	O
and	O
anti-fibrosis	O
potential	O
of	O
a	O
natural	B:C0032098
plant	I:C0032098
triterpenoid	O
,	O
Cucurbitacin	O
B	I:C0056580
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
anti-hypertrophy	O
and	O
anti-fibrosis	O
potential	O
of	O
a	O
natural	O
plant	I:C0032098
triterpenoid	B:C1519655
,	O
Cucurbitacin	O
B	I:C0056580
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
anti-hypertrophy	O
and	O
anti-fibrosis	O
potential	O
of	O
a	O
natural	O
plant	I:C0032098
triterpenoid	O
,	O
Cucurbitacin	B:C0056580
B	I:C0056580
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Aortic	B:C0185014
banding	I:C0185014
(	O
Aortic	O
banding	I:C0185014
)	O
was	O
performed	O
to	O
induce	O
cardiac	O
hypertrophy	I:C1383860
.	O

Aortic	O
banding	I:C0185014
(	O
Aortic	B:C0185014
banding	I:C0185014
)	O
was	O
performed	O
to	O
induce	O
cardiac	O
hypertrophy	I:C1383860
.	O

Aortic	O
banding	I:C0185014
(	O
Aortic	O
banding	I:C0185014
)	O
was	O
performed	O
to	O
induce	O
cardiac	B:C1383860
hypertrophy	I:C1383860
.	O

After	O
1	O
week	O
of	O
surgery	B:C0543467
,	O
mice	O
were	O
receive	O
cucurbitacin	O
B	I:C0056580
treatment	O
(	O
Gavage	O
,	O
0.2	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
2	O
day	O
)	O
.	O

After	O
1	O
week	O
of	O
surgery	O
,	O
mice	B:C0025929
were	O
receive	O
cucurbitacin	O
B	I:C0056580
treatment	O
(	O
Gavage	O
,	O
0.2	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
2	O
day	O
)	O
.	O

After	O
1	O
week	O
of	O
surgery	O
,	O
mice	O
were	O
receive	O
cucurbitacin	B:C0056580
B	I:C0056580
treatment	O
(	O
Gavage	O
,	O
0.2	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
2	O
day	O
)	O
.	O

After	O
1	O
week	O
of	O
surgery	O
,	O
mice	O
were	O
receive	O
cucurbitacin	O
B	I:C0056580
treatment	B:C0087111
(	O
Gavage	O
,	O
0.2	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
2	O
day	O
)	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	B:C0185014
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	B:C0056580
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	B:C0243095
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	B:C0243095
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	B:C0018787
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	B:C0225828
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	B:C0240035
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	B:C0012000
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	B:C0205161
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	B:C0017262
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	B:C0020564
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	B:C0005516
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	B:C0020564
mice	O
.	O

After	O
4	O
weeks	O
of	O
Aortic	O
banding	I:C0185014
,	O
cucurbitacin	O
B	I:C0056580
demonstrated	O
a	O
strong	O
anti-hypertrophy	O
and	O
-	O
fibrosis	I:C0243095
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	O
weight	O
,	O
myocardial	O
cell	I:C0225828
cross-sectional	O
area	O
and	O
interstitial	O
fibrosis	I:C0240035
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	O
abnormalities	O
,	O
normalized	O
in	O
gene	O
expression	I:C0017262
of	O
hypertrophic	O
and	O
fibrotic	O
markers	O
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	O
mice	B:C0025929
.	O

Cucurbitacin	B:C0056580
B	I:C0056580
also	O
showed	O
significant	O
hypertrophy	O
inhibitory	O
effect	I:C0243095
in	O
phenylephrine	O
stimulated	O
cardiomyocytes	O
.	O

Cucurbitacin	O
B	I:C0056580
also	O
showed	O
significant	O
hypertrophy	B:C0020564
inhibitory	O
effect	I:C0243095
in	O
phenylephrine	O
stimulated	O
cardiomyocytes	O
.	O

Cucurbitacin	O
B	I:C0056580
also	O
showed	O
significant	O
hypertrophy	O
inhibitory	B:C0243095
effect	I:C0243095
in	O
phenylephrine	O
stimulated	O
cardiomyocytes	O
.	O

Cucurbitacin	O
B	I:C0056580
also	O
showed	O
significant	O
hypertrophy	O
inhibitory	O
effect	I:C0243095
in	O
phenylephrine	B:C0031469
stimulated	O
cardiomyocytes	O
.	O

Cucurbitacin	O
B	I:C0056580
also	O
showed	O
significant	O
hypertrophy	O
inhibitory	O
effect	I:C0243095
in	O
phenylephrine	O
stimulated	O
cardiomyocytes	B:C0225828
.	O

The	O
Cucurbitacin	B:C0056580
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	B:C1383860
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	B:C0004391
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	B:C0164786
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	B:C1453984
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	B:C1506134
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	B:C0037080
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	B:C4307495
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	B:C2933427
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	B:C0047569
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	B:C0164786
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	B:C2987634
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	B:C0243077
and	O
autophagy	O
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	B:C0004391
inhibitor	O
in	O
vitro	O
.	O

The	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
mitigated	O
cardiac	O
hypertrophy	I:C1383860
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	O
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
Akt	O
/	O
mTOR	O
/	O
FoxO3a	O
signal	O
pathway	I:C0037080
,	O
validated	O
by	O
SC79	O
,	O
MK2206	O
,	O
and	O
3	O
-	I:C0047569
MA	I:C0047569
,	O
the	O
Akt	O
agonist	O
,	O
inhibitor	O
and	O
autophagy	O
inhibitor	B:C0243077
in	O
vitro	O
.	O

The	O
overexpression	B:C1514559
of	O
constitutively	O
active	O

Akt	B:C0164786
completely	O
abolished	O
the	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
protection	O
of	O
cardiac	O
hypertrophy	I:C1383860
in	O
human	O
cardiomyocytes	O
AC16	I:C0225828
.	O

Akt	O
completely	O
abolished	O
the	O
Cucurbitacin	B:C0056580
B	I:C0056580
-	O
mediated	O
protection	O
of	O
cardiac	O
hypertrophy	I:C1383860
in	O
human	O
cardiomyocytes	O
AC16	I:C0225828
.	O

Akt	O
completely	O
abolished	O
the	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
protection	O
of	O
cardiac	B:C1383860
hypertrophy	I:C1383860
in	O
human	O
cardiomyocytes	O
AC16	I:C0225828
.	O

Akt	O
completely	O
abolished	O
the	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
protection	O
of	O
cardiac	O
hypertrophy	I:C1383860
in	O
human	B:C0086418
cardiomyocytes	O
AC16	I:C0225828
.	O

Akt	O
completely	O
abolished	O
the	O
Cucurbitacin	O
B	I:C0056580
-	O
mediated	O
protection	O
of	O
cardiac	O
hypertrophy	I:C1383860
in	O
human	O
cardiomyocytes	B:C0225828
AC16	I:C0225828
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	B:C0056580
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	O
/	O
mTOR	O
/	O
Fox	O
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	B:C1383860
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	O
/	O
mTOR	O
/	O
Fox	O
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	B:C0004391
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	O
/	O
mTOR	O
/	O
Fox	O
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	B:C0225828
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	O
/	O
mTOR	O
/	O
Fox	O
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	B:C1519312
of	O
Akt	O
/	O
mTOR	O
/	O
Fox	O
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	B:C0164786
/	O
mTOR	O
/	O
Fox	O
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	O
/	O
mTOR	B:C1453984
/	O
Fox	O
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	O
/	O
mTOR	O
/	O
Fox	B:C1506134
O3a	I:C1506134
signal	O
axis	I:C0037080
.	O

Collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cucurbitacin	O
B	I:C0056580
protects	O
against	O
cardiac	O
hypertrophy	I:C1383860
through	O
increasing	O
the	O
autophagy	O
level	O
in	O
cardiomyocytes	O
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	O
of	O
Akt	O
/	O
mTOR	O
/	O
Fox	O
O3a	I:C1506134
signal	B:C0037080
axis	I:C0037080
.	O

